https://www.selleckchem.com/products/epz015666.html Following the FACTOR algorithm, overall procedural success was achieved in 143 out of 150 patients (95%). Successful antegrade CTO crossing occurred in 59%; success rates increased to 85% when additional retrograde popliteal, tibiopedal, and direct SFA accesses were used. In multivariate analysis, retrograde wire crossing, stent placement, and atherectomy were independent predictors of successful revascularization. The results of our study show that utilization of the FACTOR score and algorithm can result in high rates of successful SFA-CTO revascularization. The results of our study show that utilization of the FACTOR score and algorithm can result in high rates of successful SFA-CTO revascularization. Robotic percutaneous coronary intervention (R-PCI) results in comparable outcomes to manual PCI in the treatment of obstructive coronary artery disease (CAD). The objective of this study is to evaluate the cost and resource utilization of R-PCI compared with manual PCI. Consecutive patients with CAD undergoing elective R-PCI or manual PCI over an 18-month period by a single operator were included. Procedure-related costs and resource utilization were analyzed and propensity adjusted to account for differences in baseline demographic and lesion characteristics. A total of 164 patients (mean age, 68.9 ± 10.8 years; 81% men) underwent R-PCI (n = 56) or manual PCI (n = 108). The R-PCI group demonstrated higher Syntax scores (17.8 ± 12.9% vs 11.8 ± 7.7%; P<.01) and a greater proportion of type B2/C lesions (89.3% vs 69.4%; P<.01). R-PCI was associated with higher unadjusted costs of total hospitalization ($8219.90 ± 336.60 vs $7268.50 ± 220.10; P=.02) and direct supplies ($4711.10 ± 239.90 vs $3809.40 ± 166.80; P<.01). Following propensity-matched analysis, R-PCI was associated with higher direct supply costs alone, without a significant difference in total hospitalization or catheterization laboratory cost. Furthermore,